Mayo Clinic Researchers Say Triple Drug Combination is Promising Option

from PRNewswire -- Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.